(Q40880445)

English

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers (English)

1 reference

Europe PubMed Central

24 September 2017

0 references

author name string

Vetto JT

1

1 reference

Europe PubMed Central

24 September 2017

Lum S

2

1 reference

Europe PubMed Central

24 September 2017

Morris A

3

1 reference

Europe PubMed Central

24 September 2017

Sicotte M

4

1 reference

Europe PubMed Central

24 September 2017

Davis J

5

1 reference

Europe PubMed Central

24 September 2017

Lemon M

6

1 reference

Europe PubMed Central

24 September 2017

Weinberg A

7

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 September 1997

1 reference

Europe PubMed Central

24 September 2017

The American Journal of Surgery

1 reference

Europe PubMed Central

24 September 2017

174

1 reference

Europe PubMed Central

24 September 2017

258-265

1 reference

Europe PubMed Central

24 September 2017

3

1 reference

Europe PubMed Central

24 September 2017

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

High gradient magnetic cell separation with MACS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

CD27: marker and mediator of T-cell activation?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

CD40 ligand and its role in X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

T-lymphocyte entry into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Immunotherapy of malignancy by in vivo gene transfer into tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900139-6

7 January 2021

Identifiers

10.1016/S0002-9610(97)00139-6

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40880445&oldid=1909447480"